Medtronic Invests up to $80M in Medtech Company Pi-Cardia with a Potential Buyout on the Table

Medtronic invests up to $80M in medtech company Pi-Cardia with a potential buyout on the table

Less than a year after investing heavily in Minnesota-based Anteris Technologies, Medtronic has announced a new strategic investment in Pi-Cardia. The TAVR technology at the heart of this investment is Pi-Cardia's FDA-approved ShortCut device.

Medtronic invests in leaflet modification specialist Pi-Cardia

Medtronic has announced a strategic investment in Pi-Cardia, developer of ShortCut and other leaflet modification technologies for the treatment of heart valve disease. With a focus on addressing the evolving needs of increasingly complex transcatheter aortic valve implantation (TAVI) patients and procedures, Medtronic secures an option for strengthening its structural heart portfolio through the investment, […] The post Medtronic invests in lea…